Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. - Henrich,KO.; Fischer,M.; Mertens,D.; Benner,A.; Wiedemeyer,R.; Brors,B.; Oberthuer,A.; Berthold,F.; Wei,JS.; Khan,J.; Schwab,M.; Westermann,F. (Clin Cancer Res, 2006)